Drug Type Small molecule drug |
Synonyms A2A-O-04 |
Target |
Mechanism TACC3 inhibitors(Transforming acidic coiled protein 3 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization ![]() |
Active Organization- |
Inactive Organization ![]() |
Drug Highest PhasePendingEarly Phase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Leukemia | Phase 1 | US | A2a Pharmaceuticals, Inc.Startup | 05 Dec 2021 |
Solid tumor | Phase 1 | US | A2a Pharmaceuticals, Inc.Startup | 05 Dec 2021 |